Search

everythinglearnresearchcommunity

for

Search:↓

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Glucocorticoid treatment in lupus can cause oral lesions, which need early diagnosis and comprehensive care.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Hair loss in Cronkhite-Canada syndrome may be caused by autoimmune factors, not just stress or malabsorption.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Topical treatment is recommended for Folliculitis decalvans in pregnant women.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Early recognition and aggressive treatment can significantly improve rare ANA-negative lupus with heart and skin issues.

People with advanced chronic kidney disease often have skin problems, which can be treated with various medications and procedures to improve their quality of life.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Both patients and physicians are often dissatisfied with the control of systemic lupus erythematosus and lupus nephritis.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Early diagnosis and treatment of myositis in SLE patients lead to better outcomes.

These new skin treatments are safer and more effective with minimal side effects.

A combined treatment with microneedling and vitamin D3 led to complete hair regrowth in a woman with stubborn patch alopecia areata.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.